How long do I need to take sotorasiib targeted drug?

Sotorasib is a targeted drug specifically targeting KRAS G12C mutations and is mainly used for the treatment of non-small cell lung cancer (NSCLC). There is no fixed standard for the duration of medication, which mainly depends on the patient's individual response, efficacy and whether serious side effects occur. Typically, patients will continue taking sotorasiib until their disease progresses, they cannot tolerate the side effects of the drug, or they discontinue treatment for other reasons.

The goals of sotoracib treatment are to delay disease progression, shrink tumors, and improve patients' quality of life. Therefore, efficacy evaluation is usually performed after a period of treatment. If the patient's condition is stable or even improved over a period of time, and no new metastasis or spread occurs, doctors usually recommend continuing to take sotorasib to maintain the effect. According to clinical studies, sotorasib has shown significant effects in prolonging progression-free survival (PFS), with many patients achieving disease control for several months or even longer after receiving treatment.

Common side effects of sotorasiib include diarrhea, fatigue, nausea, abnormal liver function, etc. Mild or moderate adverse reactions can usually be managed with dose adjustments or adjunctive medications so that the patient can continue treatment. However, if a patient experiences severe side effects, the doctor may recommend reducing the dose, taking the medication intermittently, or permanently discontinuing the medication.

The specific duration of medication varies from person to person, and there are individual differences in treatment tolerance and drug effects among different patients. Doctors will adjust the treatment plan based on comprehensive factors such as the patient's health status, tumor characteristics, and imaging examinations. In addition, during long-term treatment, doctors will regularly track the patient's condition progress and judge the efficacy through imaging and blood indicators and other examinations.

In general, the length of time you should take sotoraxib depends on efficacy, tolerability, and individual health. Patients should follow the doctor's instructions, conduct regular check-ups, pay close attention to their body's reaction while taking the medicine, and communicate with the doctor in a timely manner.